Evidence map›Paper›PMID 26895826›Full record

ArticleTrials2016

From protocol to published report: a study of consistency in the reporting of academic drug trials.

Louise Berendt, Torbjörn Callréus, Lene Grejs Petersen, Karin Friis Bach, Henrik Enghusen Poulsen, Kim Dalhoff

Abstract read
In one paragraph

Article in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Louise BerendtThe GCP Unit at Copenhagen University Hospital, Bispebjerg University Hospital, Copenhagen, Denmark. lbe@berendt.eu.
Torbjörn CallréusMedicines Development & Clinical Trials, Danish Health and Medicines Authority, Copenhagen, Denmark. tca@dkma.dk.
Lene Grejs PetersenMedicines Development & Clinical Trials, Danish Health and Medicines Authority, Copenhagen, Denmark. lgp@dkma.dk.
Karin Friis BachThe GCP Unit at Copenhagen University Hospital, Bispebjerg University Hospital, Copenhagen, Denmark. karin@friisbach.dk.
Henrik Enghusen PoulsenDepartment of Clinical Pharmacology, Bispebjerg University Hospital, Copenhagen, Denmark. hepo@rh.dk.
Kim DalhoffDepartment of Clinical Pharmacology, Bispebjerg University Hospital, Copenhagen, Denmark. kim.peder.dalhoff@regionh.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnacknowledged inconsistencies in the reporting of clinical trials undermine the validity of the results of the trials. Little is known about inconsistency in the reporting of academic clinical drug trials. Therefore, we investigated the prevalence of consistency between protocols and published reports of academic clinical drug trials.

methodsA comparison was made between study protocols and their corresponding published reports. We assessed the overall consistency, which was defined as the absence of discrepancy regarding study type (categorized as either exploratory or confirmatory), primary objective, primary endpoint, and--for confirmatory trials only--hypothesis and sample size calculation. We used logistic regression, χ(2), and Fisher's exact test.

resultsA total of 282 applications of academic clinical drug trials were submitted to the Danish Health and Medicines Authority in 1999, 2001, and 2003, 95 of which fulfilled the eligibility criteria and had at least one corresponding published report reporting data on trial subjects. Overall consistency was observed in 39% of the trials (95% CI: 29 to 49%). Randomized controlled trials (RCTs) constituted 72% (95% CI: 63 to 81%) of the sample, and 87% (95% CI: 80 to 94%) of the trials were hospital based.

conclusionsOverall consistency between protocols and their corresponding published reports was low. Motivators for the inconsistencies are unknown but do not seem restricted to economic incentives.

Indexed as

Clinical ProtocolsAcademies and InstitutesClinical Trials as TopicHumansLogistic ModelsResearch DesignSample Size

Identifiers

PMID26895826
PMCPMC4761223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.